[ad_1] Brokerage firm Jefferies has a target of 26,600 for the Nifty 50 index for the calendar year 2025. The target implies a potential upside of 10% from current levels on the Index. Company Value Change %Change The brokerage said that the one-year forward price-to-earnings multiple for the Nifty is trading above its five-year average […]
Biocon EPS estimates cut by 38% by Nuvama who sees challenges for Sun Pharma, Cipla – CNBC TV18
[ad_1] Brokerage firm Nuvama has cut Biocon Ltd.’s Earnings Per Share (EPS) estimates by 38% for financial year 2025 as it expects struggles for the company’s generics business. A USFDA clearence to the Bengaluru unit, litigation outcome of the Aflibercept, a reinspection of the Malaysia unit and financial deleveraging along with a recovery in Syngene […]
Trade Setup for November 4: Nifty heads into a week dominated by global cues with lows in focus – CNBC TV18
[ad_1] It has been a volatile last two weeks for the Nifty, having ended October on a negative note. The month saw the index fall 6%, marking its worst monthly drop since March 2020. Relentless selling from foreign institutions, who sold in every single session during the month, coupled with earnings disappointments, added to the […]
Why Sun Pharma may be in focus on Monday – CNBC TV18
[ad_1] Sun Pharmaceutical Industries is likely to attract attention on Monday (November 4) following a recent US court ruling that has delayed the launch of its new drug, LEQSELVITM (deuruxolitinib). The US District Court of New Jersey issued a preliminary injunction, which blocks Sun Pharma from introducing the medication, intended for treating severe alopecia areata, […]
Sun Pharma to acquire more than 5% stake in Pharmazz for up to $15 million – CNBC TV18
[ad_1] Sun Pharmaceuticals Industries, India’s largest drugmaker informed the exchanges on Wednesday that it has entered into an agreement with Pharmazz Inc., based out of Delaware, US, to acquire a more than 5% stake in the company for an aggregate investment of up to $15 million in cash. Sun Pharma has called this a strategic […]
Nifty Approaches 25,000: Market Insights and Future Projections
In typical market terms, waiting three to five years tests patience. However, in the recent volatile market, even waiting three days for a milestone can be trying. Currently, the Nifty is just 49 points away from the 25,000 mark. It came within 0.2 points on Monday, 30 points on Tuesday, and 16 points on Wednesday […]